1. Inserm U1018, Université Paris-Saclay, UVSQ, Université Paris-Sud, Villejuif, France;
2. Service de Néphrologie, Hôpital Ambroise Paré APHP, Boulogne-Billancourt, France;
3. Department of Nephrology, University of Medicine and Pharmacy “Gr. T. Popa”, Iasi, Romania;
4. Institute of Nutrition, Friedrich Schiller University Jena, Jena, Germany;
5. Vth Department of Medicine (Nephrology, Hypertensiology, Endocrinology, Diabetology, Rheumatology), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany;
6. Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University Graz, Graz, Austria;
7. Synlab Academy, Synlab Holding Deutschland GmbH, Mannheim, Germany;
8. Inserm, Centre d’Investigations Cliniques - Plurithématique 14-33, and Inserm U1116, CHU de Nancy, and Université de Lorraine, France and F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France;
9. Association Lorraine de Traitement de l’Insuffisance Rénale (ALTIR), Vandoeuvre-lès-Nancy, France;
10. British Heart Foundation Glasgow Cardiovascular Research Centre, Glasgow, UK;
11. Rikshospitalet, Oslo, Norway;
12. University Hospital, Uppsala, Sweden;
13. University Hospital, Erlangen-Nürnberg, Erlangen, Germany